Editorial
 DISMAL SHOW BY GLOBAL PHARMA COS   
 Tuesday, April 26, 2016 
 The global pharmaceutical industry seems to be heading for a period of hard times looking at the performance figures of top 15 companies during 2015. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Pall Life Sciences introduces Cadence Acoustic Separator for intensified bioprocess clarification & purification applications
17:00  [IST]Epigenomics introduces colorectal cancer screening test, Epi proColon in US
16:00  [IST]Oasmia Pharma reports positive results from phase III study of Paclical/Apealea in ovarian cancer
15:45  [IST]Sanofi net earnings up by 6.2% to €1,087 mn in Q1
15:30  [IST]Ajanta Pharma net surges by 43% in Q4 to Rs.106 cr
15:00  [IST]Astellas, CNTRP announce recipients of second Research Innovation Grant Competition
more news >>
TOP NEWS
08:00  [IST]Semler appoints US consultant to make detailed response to US FDA's charges of data integrity
08:00  [IST]World’s single largest vaccine alert programme gets one million registrations in India
08:00  [IST]TeamLease sees hiring traction by pharma cos driven by attrition & expansion with salary hikes between 11-13%
08:00  [IST]Vacancies of 16 drug inspectors, 2 deputy directors at TN DCA may be filled after election
08:00  [IST]Commerce secretary urges pharma industry to triple capacity and production to capture 10% share in global market
08:00  [IST]TN Ayush drug manufacturers claim that potential alternatives are available in Ayush to replace banned FDCs
more news >>
YESTERDAY'S NEWS
18:00  [IST]J&J Consumer to buy leading dermocosmetics company, NeoStrata
17:10  [IST]DSM Sinochem appoints Anurag Roy as its new business unit director for Asia Pacific, ME & Africa
17:00  [IST]Biocept initiates collaborative liquid biopsy study with MedStar Georgetown University Hospital
16:55  [IST]Abbott to buy US based medical device firm St Jude Medical for $25 billion
16:15  [IST]Lupin re-launches Methergine oral tablets in US
15:20  [IST]GlaxoSmithKline adjusted net dips by 96% in Q1 to £352 mn
more news >>
INTERVIEW  
Need for screening patients with high risk of aortic disease: Tony Semedo
Medtronic Tony Semedo, Senior vice president
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |